About jeff geschwind
Originally from France, Jean-Francois Geschwind (Jeff Geschwind) earned his medical degree in the United States from Boston University School of Medicine (BUSM). After this, Jeff went on to complete his medical residency training in diagnostic radiology at the University of California at San Francisco (UCSF) as a Resident-Scholar sponsored by the National Institutes of Health (NIH).
Jeff has worked for a variety of medical organizations, including the
American Society of Clinical Oncology, the Hepatobiliary Task Force of the National Cancer Institute, the Radiological Society of North America, the American Association for Cancer Research, the International Liver Cancer Association and remain an active member of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiology Society of Europe. In addition to this, Jeff Geschwind is a Diplomate of the American Board of Radiology. Throughout his time here, he has received his a number of awards, including the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who.
In addition to his hands-on medical experience, Dr. Geschwind has authored or co-authored hundreds of scientific articles that largely focus on the interplay of liver cancer and interventional oncology – the newest and fastest growing branch of interventional radiology. As someone on the forefront of the new technology and therapies that are helping to transforming the existing world of cancer care, Jeff felt led to start a new company during his time on faculty at Johns Hopkins in order to bring this new promising drug therapy to the clinic.
Jeff Geschwind recently became the Director of Oncology at USA Vein Clinics and USA Fibroied and Vascular Centers. Here, he is dedicated to to developing centers where cancer patients can find treatment with help from the world’s finest physicians and cutting-edge technology that offer minimally invasive, image-guided procedures on an outpatient basis.